// App-Quantinova.ai

: Dabigatran Etexilate: Efficacy and Safety in the Treatment of Localized Intravascular Coagulopathy Associated with Venous Malformations

Researchers

Presenter

  • C. Hermans

Principal Investigators

  • C. Lambert

Medical Centers

  • Cliniques universitaires Saint‐Luc, Haemostasis and Thrombosis Unit ‐ Division of Haematology, Brussels, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous malformations

  • Venous thrombosis

Biomarkers

  • Fibrinogen

  • Activated partial thromboplastin time

Drug/Treatment

  • Pradax

  • Fibrinogen (IV)

  • Evithrom

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A